XML 15 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Revenue        
Product sales $ 2,170,491 $ 1,676,480 $ 6,051,354 $ 3,599,770
Licensing revenue    5,000 609,167 15,000
Total revenue 2,170,491 1,681,480 6,660,521 3,614,770
Cost of product sales 1,281,634 1,086,031 3,817,737 2,073,909
Gross profit 888,857 595,449 2,842,784 1,540,861
Operating expenses        
Research and development 160,528 110,689 361,404 353,837
Sales and marketing 208,080 145,735 625,600 379,774
General and administrative 630,342 487,733 1,856,386 1,441,852
Total operating expenses 998,950 744,157 2,843,390 2,175,463
Operating loss (110,093) (148,708) (606) (634,602)
Other income (expenses)        
Other income          94,253
Interest expense (185,554) (185,554) (556,664) (547,875)
Gain on disposal of property and equipment    431    368
Amortization of deferred financing costs (14,263) (18,397) (42,322) (60,142)
Total other income (expenses) (199,817) (203,520) (598,986) (513,396)
Net Loss $ (309,910) $ (352,228) $ (599,592) $ (1,147,998)
Basic and diluted net loss per common share $ 0.00 $ (0.01) $ (0.01) $ (0.02)
Basic and diluted weighted average common shares used to calculate net loss per common share 70,106,312 69,679,854 70,005,207 69,679,854